Rosuvastatin News and Research

RSS
FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Simple blood test may predict people at highest risk for developing heart problems

Simple blood test may predict people at highest risk for developing heart problems

Experimental agent fails to increase HDL levels, reveals new study

Experimental agent fails to increase HDL levels, reveals new study

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Study finds that high potency statins can beat dementia

Study finds that high potency statins can beat dementia

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Stopping cholesterol drugs may increase risk of Parkinson's disease

Stopping cholesterol drugs may increase risk of Parkinson's disease

Omthera to be acquired by AstraZeneca

Omthera to be acquired by AstraZeneca

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

High-dose rosuvastatin reduces acute kidney injury caused by imaging dye in ACS patients

High-dose rosuvastatin reduces acute kidney injury caused by imaging dye in ACS patients

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Statin effect on thrombosis not so positive

Statin effect on thrombosis not so positive

Statin's potency may cause muscle problems in patients with cardiovascular disease

Statin's potency may cause muscle problems in patients with cardiovascular disease

Individuals on statins more likely to experience fatigue with exertion

Individuals on statins more likely to experience fatigue with exertion

BHD launches Statin Induced Myopathy Genotype test

BHD launches Statin Induced Myopathy Genotype test

Resverlogix completes RVX-208 Phase 2b trial on CVD

Resverlogix completes RVX-208 Phase 2b trial on CVD

Discontinuance of statin therapy increases CVD mortality risk in RA patients

Discontinuance of statin therapy increases CVD mortality risk in RA patients

Mount Sinai researchers present 86 abstracts and plenary sessions at ACC meeting

Mount Sinai researchers present 86 abstracts and plenary sessions at ACC meeting

Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C

Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C